Drugs / AV024
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00240877 | Aug 2002 → Aug 2003 | influenza | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AV024 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00240877 ↗ |
| Modality | Vaccine | “Monovalent vaccine of a new 6:2 reassortant” NCT00240877 ↗ |
| Route | Intranasal | “administered intranasal by spray applicator” NCT00240877 ↗ |